Transformation to small cell lung cancer after first-line afatinib treatment
Sign Up to like & getrecommendations! Published in 2018 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2018.02.011
Abstract: Acquiring resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is inevitable. Transformation to small cell lung cancer (SCLC) is reported as a possible mechanism of this acquired resistance. We describe the case of… read more here.
Keywords: afatinib; transformation; cell lung; transformation small ... See more keywords